Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Cognitive dysfunction in patients with multiple sclerosis treated with different types of interferon beta: A randomized clinical trial.
[Assessment of the pain patients with the multiple sclerosis after applying the physiotherapy treatment].
Zebrafish: A new vertebrate model for visualizing myelination in vivo.
Effect of disease duration on personality type in multiple sclerosis patients and healthy individual.
Efficacy of mitoxantrone in neuromyelitis optica spectrum: clinical and neuroradiological study.
Evaluation of the 2015 diagnostic criteria for neuromyelitis optica spectrum disorder.
β-Amyloid: Enemy or Remedy?
Dimethyl Fumarate Protects Brain From Damage Produced by Intracerebral Hemorrhage by Mechanism Involving Nrf2.
Efficacy of delayed-release dimethyl fumarate in relapsing-remitting multiple sclerosis: integrated analysis of the phase 3 trials.
Chemokine-enhanced migration of human peripheral blood mononuclear cells is antagonized by interferon beta-1b through an effect on matrix metalloproteinase-9.
AB Science confirms the filing for the Marketing Authorization Application to the European Medicines Agency of masitinib in the treatment of pancreatic cancer
Epigenetic modifications of Dexras 1 along the nNOS pathway in an animal model of multiple sclerosis.
Oligodendroglial membrane dynamics in relation to myelin biogenesis.
Multiple sclerosis: Mitoxantrone promotes differential effects on immunocompetent cells in vitro.
Leisure time activities of Iranian patients with multiple sclerosis: a qualitative study.
Antioxidative enzymes activity and malondialdehyde concentration during mitoxantrone therapy in multiple sclerosis patients.
Effects of a 4-month Ananda Yoga Program on Physical and Mental Health Outcomes for Persons With Multiple Sclerosis.
Dysregulation of regulatory CD56(bright) NK cells/T cells interactions in multiple sclerosis.
Imaging in Pediatric Demyelinating and Inflammatory Diseases of Brain- Part 2.
Teriflunomide effect on immune response to influenza vaccine in patients with multiple sclerosis.
Alterations in serum MMP-8, MMP-9, IL-12p40 and IL-23 in multiple sclerosis patients treated with interferon-beta1b.
The budget impact of introducing delayed-release dimethyl fumarate for treatment of relapse-remitting multiple sclerosis in Canada.
Posturography in MS patients treated with high dose methylprednisolone.
A gender gap in autoimmunity.
Update on reproductive safety of current and emerging disease-modifying therapies for multiple sclerosis.
Pages
« first
‹ previous
…
47
48
49
50
51
52
53
54
55
…
next ›
last »